FDA approves Medtronic's Marquis ICD (implantable cardioverter defibrillator):
This article was originally published in Clinica
The US FDA has approved for sale the first product in Medtronic's new generation of implantable cardioverter defibrillators (ICDs). The Marquis DR dual-chamber ICD offers a charge time of just 7.5 seconds - ie the time needed before the device delivers a life-saving therapy after an abnormal heart rhythm is detected. The 36cc product also incorporates a battery that can last 7-8 years, resulting in less frequent device replacement for the patient. The device is being launched in the US, Canada and Europe, says the firm.